Altered NMDA sensitivity and learning following chronic developmental NMDA antagonism

Physiology and Behavior

Volumn 62, Issue 5, 1997, Pages 955-962

  Brooks, William James ^a   Weeks, Andrew C W ^a   Leboutillier, Janelle C ^a   Petit, Ted L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Development; Learning; NMDA; Seizures

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; SYNAPTOGENESIS;

EID: 0030772617     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00169-8     Document Type: Article

References (85)

1. Anis, N. A.; Berry, S. C.; Burton, N. R.; Lodge, D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br. J. Pharm. 79:565-575; 1983.
2. Artola, A.; Singer, W. Long-term potentiation and NMDA receptors in rat visual cortex. Nature 330:649-652; 1987.
3. Balster, R. L.; Baird, J. B. Effects of phencyclidine, d-amphetamine and pentobarbitol on spaced responding in mice. Pharmacol. Biochem. Behav. 11:617-623; 1979.
4. Baudry, M.; Arst, D.; Oliver, M.; Lynch, G. Development of glutamate binding sites and their regulation by calcium in rat hippocampus. Dev. Brain Res. 1:37-48; 1981.
5. Ben-Ari, Y.; Cherubini, E.; Krnjevic, K. Changes in voltage dependence of NMDA currents during development. Neurosci. Lett. 94:88-92; 1988.
6. Benvenga, M. J.; Spaulding, T. C. Amnesic effect of the novel anticonvulsant MK-801. Pharmacol. Biochem. Behav. 30:205-207; 1988.
7. Bode-Greuel, K. M.; Singer, W. The development of N-methyl-D-aspartate receptors in cat visual cortex. Dev. Brain Res. 46:197-204; 1989.
8. Brooks, W. J.; Petit, T. L.; LeBoutillier, J. C. Neural development following NMDA administration in the rat:An electron microscopic examination of the occipital neocortex layer I. Brain Res. Bull. 33:621-624; 1994.
9. Brooks, W. J.; Petit, T. L.; LeBoutillier, J. C. The effect of chronic administration of NMDA antagonists on synaptic development. Synapse 26:104-113; 1997.
10. Carmignoto, G.; Vicini, S. Activity-dependent decrease in NMDA receptor responses during development of the visual cortex. Science 258:1007-1011; 1992.
11. Collingridge, G. L.; Kehl, S. L.; McLennan, H. Excitatory amino acids in synaptic transmission in the schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. (Lond) 334:33-46; 1983.
12. Creese, I.; Burt, D. R.; Snyder, S. H. Dopamine receptor binding enhancement accompanies lesion induced behavioral super-sensitivity. Science 197:596-598; 1977.
13. Creese, I.; Snyder, S. H. Behavioral and biochemical properties of the dopamine receptor. In:Lipton, M. A.; DiMascio, A.; Killam, K. F., eds. Psychopharmacology: A generation of progress. New York: Raven Press; 1978:377-388.
14. Crepel, F.; Dupont, J. L.; Gardette, R. Connectivity and chemosensitivity of Purkinje cells in the immature rat cerebellum: an in vitro study. J. Physiol. (Lond) 332:62; 1982.
15. Czuczwar, S. J.; Frey, H.; Loscher, W. Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by anti-epileptic drugs and other agents. Eur. J. Pharmacol. 108:273-280; 1985.
16. Czuczwar, S. J.; Meldrum, B. S. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur. J. Pharmacol. 83:335-338; 1982.
17. Davis, S.; Butcher, S. P.; Morris, R. G. The NMDA receptor antagonist D2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J. Neurosci. 12:21-34; 1992.
18. Farber, N. B.; Price, M. T.; Labruyere, J.; Fuller, T. A.; Olney, J. W. Age dependency of NMDA antagonist neurotoxicity. Soc. Neurosci. Abstr. 18:1148; 1993.
19. Fix, A. S.; Long, G. G.; Wozniak, D. F.; Olney, J. W. Pathomorphologic effects of N-methyl-D-Aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex: A review. Drug Dev. Res. 32:147-152; 1994.
20. Fix, A. S.; Wightman, K. A.; Johnson, C. A.; Truex, L.; Smith, R.; Gomez, E.; Long, G. G.; Storts, R. W. Dose-dependent neuronal degeneration induced by the NMDA antagonist MK(+)801 in the rat cerebral cortex. Vet. Pathol. 29:447; 1993.
21. Ferkany, S. W.; Borosky, S. A.; Clissold, D. B.; Ponte-Corvo, M. J. Dextromethorphan inhibits NMDA induced convulsions. Eur. J. Pharmacol. 151:151-154; 1988.
22. Garthwaite, G.; Yamini, B.; Garthwaite, J. Selective loss of purkinje and granule cell responsiveness to N-methyl-D-aspartate in rat cerebellum during development. Dev. Brain Res. 36:288-292; 1987.
23. Geyer, M. A.; Segal, D. S.; Greenberg, B. D. Increased startle responding in rats treated with phencyclidine. Neurobehav. Toxicol. Teratol. 6:161-164; 1984.
24. Gu, Q.; Bear, M. F.; Singer, W. Blockade of NMDA-receptors prevents ocularity changes in kitten visual cortex after reversed monocular deprivation. Dev. Brain Res. 47:281-288; 1989.
25. Hamon, B.; Heinemann, U. Developmental changes in neuronal sensitivity to excitatory amino acids in area CAl of the rat hippocampus. Dev. Brain Res. 38:286-290; 1988.
26. Handelmann, G. E.; Contreras, P. C.; O'Donohue, T. L. Selective memory impairment by phencyclidine in rats. Eur. J. Pharmacol. 140:69-73; 1987.
27. Harris, E. W.; Ganong, A. H.; Cotman, C. W. Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res. 323:132-137; 1984.
28. Ingram, K. K.; Garofalo, P.; Spangler, E. L.; Mantione, C. R.; Odano, I.; London, E. D. Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in rats. Brain Res. 580:273-80; 1992.
29. Iwakiri, M.; Komatsu, Y. Postnatal development of NMDA receptor-mediated synaptic transmission in cat visual cortex. Dev. Brain Res. 74:89-97; 1993.
30. Jerusalinsky, D.; Ferreira, M. B.; Walz, R.; DaSilva, R. C.; Bianchin, M.; Ruschel, A. C.; Zanatta, M. S.; Medina, J. H.; Izquierdo, I. Amnesia by posttraining infusion of glutamate receptor antagonists into the amygdala, hippocampus, and entorhinal cortex. Behav. Neural Biol. 58:76-80; 1992.
31. Johnson, L. C.; DeNoble, V. J. N-methyl-D-aspartic acid (NMDA) induced convulsions in mice: An in vivo model to identify NMDA antagonists. Soc. Neurosci. Abstr. 98:20; 1988.
32. Johnston, M. V.; Silverstein, F. S.; McDonald, J. W. MK-801 pretreatment enhances NMDA mediated brain injury and alters NMDA receptor and PCP receptor binding characteristics in perinatal rats. Soc. Neurosci Abstr. 18:299; 1988.
33. Keseberg, U.; Schmidt, W. J. Low-dose challenge by the NMDA receptor antagonist dizocilpine exacerbates the spatial learning deficit in entorhinal cortex lesioned rats. Behav. Brain Res. 67:255-261; 1995.
34. Kesner, R. P.; Dakis, M.; Bolland, B. L. Phencyclidine disrupts long-but not short-term memory within a spatial learning task. Psychopharmacology 111:85-90; 1993.
35. Kesner, R. P.; Hardy, J. D.; Novak, J. M. Phencyclidine and behavior: II. Active avoidance learning and radial arm maze performance. Pharmacol. Biochem. Behav. 18:351-356; 1983.
36. Kim, M.; McGaugh, J. L. Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance. Brain Res. 585:35-48; 1992.
37. Kirkwood, A.; Lee, H. K.; Bear, M. F. Co-regulation of long-term potentiation and experience-dependent synaptic plasticity in visual cortex by age and experience. Nature 375:328-331; 1995.
38. Kleinschmidt, A.; Bear, M. F.; Singer, W. Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex. Science 238:355-357; 1987.
39. Labruyere, J.; Price, M. T.; Olney, J. W. NMDA antagonists induce pathomorphological changes in cerebrocortical neurons. Soc. Neurosci. Abstr. 15:761; 1989.
40. Leander, J. D.; Lawson, R. R.; Ornstein, P. L.; Zimmerman, D. M. N-methyl-d-aspartic acid-induced lethality in mice: Selective antagonism by phencyclidine-like drugs. Brain Res. 448:115-120; 1988.
41. Lehmann, J.; Schneider, J.; McPherson, S.; Murphy, D. E.; Bernard, P.; Tsai, C.; Bennett, D. A.; Pastor, G.; Steel, D. J.; Boehm, C.; Cheney, D. L.; Liebmann, J. M.; Williams, M.; Wood, P. L. CPP, a selective N-methyl-D- aspartate (NMDA)-type receptor antagonist: Characterization in vitro and in vivo. J Pharmacol. Exp. Ther. 240:737-746; 1987.
42. Liang, K. C.; Hon, W.; Davis, M. Pre and posttraining infusion of N-methyl-D-aspartate receptor antagonists into the amygdala impair memory in an inhibitory avoidance task. Behav. Neurosci. 108:241-253; 1994.
43. Lodge, D.; Berry, S. C.; Church, J.; Martin, D.; McGhee, A.; Lai, H-M.; Thomson, A. M. Isomers of cyclazocine as excitatory amino acid antagonists. Neuropeptides 5:245-248; 1984.
44. Luhmann, H. J.; Prince, D. A. Transient expression of polysynaptic NMDA receptor-mediated activity during neocortical development. Neurosci. Lett. 111:109-115; 1990.
45. MacDonald, J. F.; Miljkovic, Z.; Pennefather, P. Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J. Neurophysiol. 58:251-266; 1987.
46. Maragos, W. F.; Chu, C. M.; Greenamyre, J. T.; Penney, J. B.; Young, A. B. High correlation between the localization of [3H]TCP binding and NMDA receptors. Eur. J. Pharmacol. 123:173-174; 1986.
47. Maragos, W. F.; Penney, J. B.; Young, A. B. Anatomic correlation of NMDA and [3H]TCP labelled receptors in rat brain. J. Neurosci. 8:493-501; 1988.
48. McCabe, B. J.; Davey, J. E.; Horn, G. Impairment of learning by localized injection of an N-methyl-D-aspartate receptor antagonist into the hyperstriatum ventrale of the domestic chick. Behav. Neurosci. 106:947-953; 1992.
49. McCann, D. J.; Rabin, R. A.; Winter, J. C. Use of the radial arm maze in studies of phencyclidine and other drugs of abuse. Physiol. Behav. 40:805-812; 1987.
50. McDonald, J. W.; Silverstein, F. S.; Johnston, M. V. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in the developing rat central nervous system. Brain Res. 459:200-203; 1988.
51. McLamb, R. L.; Williams, L. R.; Nanry, K. P.; Wilson, W. A.; Tilson, H. A. MK-801 impedes the acquisition of a spatial memory task in rats. Pharmacol. Biochem. Behav. 37:41-45; 1990.
52. McWilliams, J. R. Age related declines in anatomical plasticity and axonal sprouting. In: Petit, T. L.; Ivy, G. O., eds. Neural plasticity: A lifespan approach. New York: Alan R. Liss; 1987.
53. Mehta, A. K.; Ticku, M. K. Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats. Life Sci. 46:37-42; 1990.
54. Meldrum, B. S.; Croucher, M. J.; Czuczwar, S. J.; Collins, J. F.; Curry, K.; Joseph, M.; Stone, T. W. A comparison of the anticonvulsant potency of 2-amino-5-phosphonopentanoic acid and 2-amino-7-phosphonoheptanoic acid. Neuroscience 9:925-930; 1983.
55. Monaghan, D. T.; Cotman, C. W. Distribution of N-methyl-D-aspartate-sensitive L-[3H] -glutamate binding sites in rat brain. J. Neurosci. 5:2909-2919; 1985.
56. Mondadori, C.; Weiskrantz, L.; Buerki, H.; Petschke, F.; Fagg, G. E. NMDA receptor antagonists can enhance or impair learning performance in animals. Exp. Brain Res. 75:449-456; 1989.
57. Morris, R. G. M.; Anderson, E.; Lynch, G. S.; Baudry, M. Selective impairment of learning and blockade long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319:774-776; 1986.
58. Morris, R. G. M.; Garrud, P.; Rawlins, J. N. P.; O'Keefe, J. Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683; 1982.
59. Nabeshima, T.; Kozawa, T.; Furukawa, H.; Kameyama, T. Phencyclidine-induced retrograde amnesia in mice. Psychopharmacology 89:334-347; 1986.
60. Olney, J. W.; Gubareff, T. D.; Labruyere, J. Aminoadipate blocks the neurotoxic action of N-methyl aspartate. Life Sci. 25:537-540; 1979.
61. Olney, J. W.; Labruyere, J.; Price, M. T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362; 1989.
62. Petit, T. L. Structure and plasticity of the Hebbian synapse: The cascading events for memory storage. In: Spear, N. E.; Spear, L. P.; Woodruff, M. L., eds. Neurobehavioral plasticity: Learning, development and response to brain insults. Hillsdale, NJ: Lawrence Erlbaum Assoc; 1995:185-204.
63. Racine, R. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph. Clin. Neurophysiol. 32:281-294; 1972.
64. Ramoa, A. S.; McCormick, D. A. Enhanced activation of NMDA receptor responses at the immature retinogeniculate synapse. J. Neurosci. 14:2098-2125; 1994.
65. Scheetz, A. J.; Constantine-Paton, M. Ketamine-xylazine anaesthesia blocks consolidation of ocular dominance in kitten visual cortex. Nature 326:183-185; 1987.
66. Sepinwall, J.; Smolen, M.; Furman, S. S.; Mohacsi, E. Dextrorphan and dextromethorphan act as NMDA antagonists in vivo: Blockade of NMDA convulsions in mice. Soc. Neurosci. Abstr. 98:11; 1988.
67. Snell, L. D.; Johnson, K. M. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J. Pharmacol. Exp. Ther. 235:50-57; 1985.
68. Steele, R. J.; Stewart, M. G.; Rose, S. P. Increases in NMDA receptor binding are specifically related to memory formation for a passive avoidance task in the chick: A quantitative autoradiographic study. Brain Res. 674:352-356:1995.
69. Stringer, J. L.; Greenfield, L. J.; Hackett, J. T.; Guyenet, P. G. Blockade of long-term potentiation by phencyclidine and sigma-opiates in the hippocampus in vivo and in vitro. Brain Res. 280:127-138; 1983.
70. Sutherland, R. J.; Whishaw, I. Q.; Kolb, B. A behavioral analysis of spatial localisation following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat. Behav. Brain Res. 7:133-153; 1983.
71. Tang, A. H.; Franklin, S. R. Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats. J. Pharmacol. Exp. Ther. 225:503-508; 1983.
72. Tang, A. H.; Ho, P. M. Both competitive and non competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats. Eur. J. Pharmacol. 151:143-146; 1988.
73. Tonkiss, J.; Morris, R. G. M.; Rawlins, J. N. P. Intra-ventricular infusion of the NMDA antagonist AP5 impairs performance on a nonspatial operant DRL task in the rat. Exp. Brain Res. 72:181-188; 1988.
74. Tremblay, E.; Roisin, M. P.; Represa, A.; Charriaut-Marlangue, C.; Ben-Ari, Y. Transient increased density of NMDA binding sites in the developing rat hippocampus. Brain Res. 461:393-396; 1988.
75. Tricklebank, M. D.; Singh, L.; Oles, R. J.; Preston, C.; Iversen, S. D. The behavioral effects of MK-801: a comparison with antagonists acting noncompetitively at the NMDA receptor. Eur. J. Pharmacol. 167:127-135; 1989.
76. Trommer, B. L.; Kennelly, J. J.; Colley, P. A.; Overstreet, L. S.; Slater, N. T.; Pasternak, J. F. AP5 blocks LTP in developing rat dentate gyrus and unmasks LTD. Exp. Neurol. 131:83-92; 1995.
77. Tsumoto, T.; Hagihara, K.; Sato, H.; Hata, Y. NMDA receptors in the visual cortex of young kittens are more effective than those of adult cats. Nature 327:513-514; 1987.
78. Uckele, J.; McDonald, J. W.; O'Mara, K.; Silverstein, F. S.; Johnston, M. V. Chronic MK-801 treatment enhances NMDA recognition site binding in perinatal rats. Soc. Neurosci. Abstr. 86:2; 1989.
79. Ward, L.; Mason, S. E.; Abraham, W. C. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol. Biochem. Behav. 35:785-790; 1990.
80. Wesierska, M.; Macias-Gonzalez, R.; Bures, J. Differential effect of ketamine on the reference and working memory versions of the morris water maze task. Behav. Neurosci. 104:74-83; 1990.
81. Whishaw, I. Q.; Auer, R. N. Immediate and long-lasting effects of MK-801 on motor activity: spatial navigation in a swimming pool and EEG in the rat. Psychopharmacology 98:500-507; 1989.
82. Whishaw, I. Q.; Cassel, J-C.; Jarrard, L. E. Rats with fimria-fornix lesions display a place response in a swimming pool: a dissociation between getting there and knowing where. J. Neurosci. 15:5779-5788; 1995.
83. Wilmot, C. A. Excitatory amino acid antagonists: Behavioral and biochemical approaches for the development of new central nervous system therapeutic agents. Drug Develop. Res. 17:339-365; 1989.
84. Wozniak, D. F.; Olney, J. W.; Kettinger III, L.; Price, M.; Miller, J. P. Behavioral effects of MK-801 in the rat. Psychopharmacology 101:47-56; 1990.
85. Yanai, J; Avraham, Y; Levy, S.; Maslaton, J.; Pick, C. G.; Rogel-Fuchs, Y.; Zahalka, E. A. Alterations in septo-hippocampal cholinergic innervations and related behaviors after early exposure to heroin and phencyclidine. Dev. Brain Res. 69:207-214; 1992.